IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
Aristimuño, Carol
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study. [electronic resource] - Clinical immunology (Orlando, Fla.) Feb 2010 - 148-57 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1521-7035
10.1016/j.clim.2009.09.008 doi
Adjuvants, Immunologic--therapeutic use
CD8-Positive T-Lymphocytes--drug effects
Cell Separation
Cytokines--blood
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
Humans
Immunologic Memory--drug effects
Interferon beta-1a
Interferon-beta--therapeutic use
Longitudinal Studies
Male
Multiple Sclerosis, Relapsing-Remitting--blood
T-Lymphocyte Subsets--drug effects
T-Lymphocytes, Regulatory--drug effects
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study. [electronic resource] - Clinical immunology (Orlando, Fla.) Feb 2010 - 148-57 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1521-7035
10.1016/j.clim.2009.09.008 doi
Adjuvants, Immunologic--therapeutic use
CD8-Positive T-Lymphocytes--drug effects
Cell Separation
Cytokines--blood
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
Humans
Immunologic Memory--drug effects
Interferon beta-1a
Interferon-beta--therapeutic use
Longitudinal Studies
Male
Multiple Sclerosis, Relapsing-Remitting--blood
T-Lymphocyte Subsets--drug effects
T-Lymphocytes, Regulatory--drug effects